Cargando…
Clinical outcomes of non‐osteogenic, non‐Ewing soft‐tissue sarcoma of bone––experience of the Toronto Sarcoma Program
Non‐osteogenic, non‐Ewing soft‐tissue sarcoma (NONE‐STS) of bone is a rare presentation of primary bone cancers. Optimal treatments and outcomes for this heterogenous group are poorly described. We evaluated the factors associated with long‐term outcomes in patients with this disease. Patients with...
Autores principales: | Veitch, Zachary W., Fasih, Samir, Griffin, Anthony M., Al‐Ezzi, Esmail M., Gupta, Abha A., Ferguson, Peter C., Wunder, Jay S., Abdul Razak, Albiruni R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774718/ https://www.ncbi.nlm.nih.gov/pubmed/33063945 http://dx.doi.org/10.1002/cam4.3531 |
Ejemplares similares
-
A phase II study of ENMD-2076 in advanced soft tissue sarcoma (STS)
por: Veitch, Zachary, et al.
Publicado: (2019) -
Increased risk for other cancers in individuals with Ewing sarcoma and their relatives
por: Abbott, Diana, et al.
Publicado: (2019) -
Ewing’s Sarcoma of the Head and Neck: Margins are not just for surgeons
por: Bouaoud, Jebrane, et al.
Publicado: (2018) -
Assessment of Risk of Bias in Osteosarcoma and Ewing’s Sarcoma Randomized Controlled Trials: A Systematic Review
por: Koucheki, Robert, et al.
Publicado: (2021) -
Dysregulated heparan sulfate proteoglycan metabolism promotes Ewing sarcoma tumor growth
por: Vasileva, Elena, et al.
Publicado: (2022)